Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Arend

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
Clinical Kidney Journal|July 27, 2022
Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infectionLouise Füessl, Tobias Lau, Simon Rau, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Immunological characterization of latent tuberculosis infection in a low endemic countryRoelof A de Paus, Krista E van Meijgaarden, Corine Prins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1996
Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipientsS M Arend, R G Westendorp, F P Kroon, et al.
BMC Infectious Diseases|July 28, 2007
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individualsValérie Martinez, Guislaine Carcelain, Edgar Badell, et al.
Clinical and Vaccine Immunology : CVI|February 16, 2007
Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnelWilleke P J Franken, Joost F Timmermans, Corine Prins, et al.
The Journal of Infectious Diseases|November 26, 2002
Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasiiSandra M Arend, Krista E van Meijgaarden, Kirsten de Boer, et al.
Tuberculosis (Edinburgh, Scotland)|December 25, 2007
Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infectionSandra M Arend, Willeke P J Franken, Henrik Aggerbeck, et al.
Scandinavian Journal of Immunology|January 16, 2004
Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosisA Geluk, K E van Meijgaarden, K L M C Franken, et al.
Clinical and Vaccine Immunology : CVI|August 28, 2009
Variation in T-SPOT.TB spot interpretation between independent observers from different laboratoriesWilleke P J Franken, Steven Thijsen, Ron Wolterbeek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 21, 2020
Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017Jonathan W Uzorka, Dinah L Duinkerk, Lucia J M Kroft, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
Clinical Kidney Journal|July 27, 2022
Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infectionLouise Füessl, Tobias Lau, Simon Rau, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Immunological characterization of latent tuberculosis infection in a low endemic countryRoelof A de Paus, Krista E van Meijgaarden, Corine Prins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1996
Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipientsS M Arend, R G Westendorp, F P Kroon, et al.
BMC Infectious Diseases|July 28, 2007
T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individualsValérie Martinez, Guislaine Carcelain, Edgar Badell, et al.
Clinical and Vaccine Immunology : CVI|February 16, 2007
Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnelWilleke P J Franken, Joost F Timmermans, Corine Prins, et al.
The Journal of Infectious Diseases|November 26, 2002
Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasiiSandra M Arend, Krista E van Meijgaarden, Kirsten de Boer, et al.
Tuberculosis (Edinburgh, Scotland)|December 25, 2007
Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infectionSandra M Arend, Willeke P J Franken, Henrik Aggerbeck, et al.
Scandinavian Journal of Immunology|January 16, 2004
Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosisA Geluk, K E van Meijgaarden, K L M C Franken, et al.
Clinical and Vaccine Immunology : CVI|August 28, 2009
Variation in T-SPOT.TB spot interpretation between independent observers from different laboratoriesWilleke P J Franken, Steven Thijsen, Ron Wolterbeek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 21, 2020
Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017Jonathan W Uzorka, Dinah L Duinkerk, Lucia J M Kroft, et al.
Pageof 15